Aurobindo Pharma gets USFDA approval for Glycerol Phenylbutyrate oral liquid
Aurobindo Pharma Ltd. has received final approval from the US Food and Drug Administration (USFDA) for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, the company announced on Friday, April 17. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug, Ravicti Oral Liquid, of Horizon Therapeutics U.S. Holding LLC. The company…
